SEC Form 4 · accession 0001017491-15-000023
SEELOS THERAPEUTICS, INC. · SEEL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Barbara Troupin
Officer — Chief Medical Officer
Period of report
Jan 29, 2015
Accepted (ET)
Jan 30, 2015 · 4:33 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001017491
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $1.43 | Jan 29, 2015 | A | 50,000 | A | — | Jan 28, 2025 | Common Stock | 50,000 | 50,000 | D |
Explanation of responses
- F1The options vest on the achievement of certain clinical development milestones.